The pervasive presence of so-called ‘forever chemicals,’ previously implicated in a range of adverse health outcomes, has now been quantified: a recent US investigation revealed their detection in an astonishing 98.8 percent of 10,566 blood specimens analyzed.
Formally identified as perfluoroalkyl and polyfluoroalkyl substances (PFAS), these compounds exceed 15,000 known variants according to toxicological classification. Their designation as ‘forever chemicals’ stems from their remarkable recalcitrance to degradation and their enduring persistence within environmental matrices.
Utilized extensively across diverse industrial applications for several decades, these synthetic chemicals have infiltrated our foodstuffs, public water systems, and the planet’s intricate ecological networks.
The capacity of PFAS to enter the human organism was already understood. In this novel inquiry, researchers affiliated with NMS Labs, a prominent US-based toxicology laboratory, aimed to ascertain the prevalence and variety of PFAS co-occurring within individuals’ bloodstreams.
The empirical evidence presented in this report was compiled from 10,566 serum and plasma samples submitted to NMS Labs in Pennsylvania for comprehensive PFAS assessment.
“This extensive data repository offers a realistic depiction of how multiple PFAS compounds commonly coexist within human subjects,” stated toxicologist Laura Labay of NMS Labs.
While the dataset did not differentiate between single and multiple samples from the same individuals, it nonetheless represents a substantial cross-section of the American populace, subjected to analysis utilizing established PFAS detection methodologies.
“By pinpointing these prevalent co-exposure patterns, the study enhances our comprehension of the potential implications of widespread, combined PFAS exposure for human well-being,” Labay further commented.
A mere 0.18 percent of the analyzed samples contained solely a single type of PFAS chemical; the overwhelming majority exhibited a complex amalgamation of multiple PFAS compounds.
“The evaluation of chemical mixtures is paramount when assessing biological impacts due to the potential for additive, synergistic, or antagonistic interactions,” jointly articulated Labay and her NMS Labs colleague, toxicologist Lee Blum, in their published findings.
A consistent subset of the same PFAS was identified in the vast majority of the blood specimens. Notably, perfluorohexane sulfonic acid (PFHxS), a substance employed in the production of textiles, furnishings, and adhesives, was detected in 97.9 percent of the tested samples.
Health apprehensions associated with PFHxS, including documented adverse effects on the liver and immune function in animal models, have led to its restriction or outright prohibition in numerous jurisdictions, though the cumulative impact may already be realized.
It is highly probable that the majority of individuals have experienced exposure to a diverse spectrum of PFAS, even as researchers continue to elucidate the cumulative effects of these multiple chemical agents.
“These observations underscore the infrequent occurrence of isolated PFAS exposure events,” Labay remarked.
“Instead, individuals characteristically harbor internal burdens comprising five or more distinct PFAS, each possessing unique bioaccumulation potentials and elimination rates.
“The widespread prevalence and consistent co-occurrence of specific PFAS combinations emphasize the necessity of interpreting biomonitoring data with a focus on mixtures, particularly considering PFAS’ potential to impact multiple physiological systems within the body.”
The investigation primarily focused on thirteen of the most frequently encountered PFAS, suggesting that the reported figures may represent an underestimate of the total chemical burden.
It is pertinent to note that this study concentrated solely on the detectability of PFAS using mass spectrometry, rather than quantifying their specific concentrations within the samples.
The precise threshold of ‘forever chemical’ exposure required to elicit detrimental health effects remains an unresolved question. Current insights into PFAS’ impacts are derived from in vitro and in vivo studies, alongside observational investigations, with an accumulating body of evidence.
Research has correlated PFAS exposure with accelerated cellular senescence, neurobiological alterations, and an elevated risk for certain oncological conditions, although definitive causal linkages have not been unequivocally established.
A contributing factor to this complex issue lies in the inherent utility of PFAS. Their ability to impart water, heat, and oil resistance to products simultaneously translates into remarkable environmental longevity, complicating their breakdown processes.
While regulatory bodies and governmental entities are acknowledging the potential risks, the complete eradication of these persistent chemicals, the development of viable alternatives, and their environmental remediation present considerable, albeit not insurmountable, challenges.
The significance of these recent findings is their unequivocal demonstration of the issue’s pervasive nature and the intricate amalgamations of potentially toxic substances with which we are contending: over seventy distinct PFAS combinations were identified across the two analytical panels employed.
“We aspire for these discoveries to inform subsequent risk assessment endeavors, guide investigative priorities concerning hazardous PFAS mixtures, and ultimately facilitate more precise clinical and public health directives,” stated Labay.
